Return of the Coronavirus: 2019-nCoV

By Lisa E. Gralinski, Vineet D. Menachery. Viruses, 2020

1,248 citations recorded by the source corpus.

The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.

Subfields: Infectious Diseases, Modeling and Simulation

View Paper: https://www.semanticscholar.org/paper/1939b4ae5d05d533c51b62d01efffbdb248acafd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov) (2020, neutral): “…to severe outbreaks clusters, such as those generated by the “ Severe Acute Respiratory Syndrome ” (SARS) virus in 2003 in mainland China, and by the “ Middle East Respiratory Syndrome ” (MERS) virus in 2012 in the Kingdom of Saudi Arabia and in 2015 in South Korea (Gralinski & Menachery, 2020).”
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? (2020, background): “The incubation period of the disease is generally 3-7 days, but no longer than 14 days [5, [8] [9] [10] [11] [12] [13] [14] [15] .”
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review (2020, background): “There was an increase of infected people with no history of exposure to wildlife or visiting Wuhan, and multiple cases of infection were detected among medical professionals [2, [14] [15] [16] [17] .”
Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. (2020, neutral): “The new CoV, officially designated as the SARS coronavirus 2 (SARS-CoV-2), is a member of β -CoV lineage B, which was first identified in Wuhan by the Chinese Center for Disease Control and Prevention (CDC) (3, 4).”
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses (2020, positive): “In a ﬂuorescent study, it was conﬁrmed that the SARS-CoV-2 also uses the same ACE2 (angiotensin-converting enzyme 2) cell receptor and mechanism for the entry to host cell which is previously used by the SARS-CoV [39,40].”
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China (2020, neutral): “genome was accomplished in approximately 3 weeks from the time of the first hospitalized patient on the December 12, 2019 by Zhang's group and several others in China [91].”
Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study (2020, background): “All the COVID-19 virus sequences are visually seen in MoDMap3D generated from Test-5 (see Fig 2(b)) as a closely packed cluster and it supports a fact that there is 99% similarity among these sequences [12, 31].”
SARS-CoV-2 in wastewater: State of the knowledge and research needs (2020, neutral): “Contributing factors to the lack of appropriate animal model include the inability to cause disease without passaging the virus through a mouse host and milder disease in primates compared to humans (Gralinski and Menachery, 2020).”